- ASSISTANT PROFESSOR Population Health Science and Policy
PhD, Stony Brook University
- Jason Wang, PhD joined the Department of Health Policy of Mount Sinai School of Medicine in1996. With his doctorate in Applied Econometrics and more than 15 years of statistical analysis and SAS programming experience, he has served as Research Faculty since 2003 and Director of Data Analysis since 2005. He has a strong research background in quantitative modeling and data analyses and has many publications in scholarly journals.
Dr. Wang has been involved in various multi-site intervention projects such as a project to reduce disparities by identifying patient barriers to care; a project to work with organizations in the Chinese American Communities in NYC to raise awareness of issues regarding organ donation; a project to measure and improve the quality of health care for patients who undergo carotid endarterectomy; a project of conducting a randomized controlled trial to evaluate the cost-effectiveness of nurse management to improve health failure patients' functioning and reduce their hospitalization rates. He has also been involved in several nation-wide clinical trials such as the NIH supported SCCOR trail for the biology of human long-term mechanical circulatory support and the TERUMO DuraHeart LVAS Bridge to Transplant Trial.
R01 MH0077683-01A2 NIMHThe aim of this NIMH-funded study is to evaluate the effectiveness in a randomized controlled trial of a patient education intervention to reduce the frequency of depressive symptoms among White, non-Hispanic, and non-Black minority postpartum mothers.
NIH/NHLBI; P50 HL77096-01SCCOR Grant: The Biology of Human Long-Term Mechanical Circulatory Support
Center for Achieving and Sustaining Improved Health in Harlem 2P60MD000270-06 NCMHDThis Center will advance the science of developing, deploying and evaluating interventions in minority communities to reduce documented disparities in health and health care.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr.Wang is not currently required to report Industry relationships.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
East Building, Room 2-54
1425 Madison Avenue Box 1077
New York, NY 10029